Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study

<div>Graft loss from antibody-mediated rejection in high-risk sensitized patients with and without C1q-binding posttransplant donor-specific HLA antibodies (DSA) (a) and in patients who in addition to pretransplant DSA positivity had also increased levels of the immune activation marker sCD30 before transplantation (b).</div>

Journal of Immunology Research

fig3

Figure 3

Figure 3: Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study 

Figure 3 | Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study 